This inventor holds 2 USPTO granted patents. Top assignees: University of California, Bachem Americas, Inc.. Active years: 2015-2017.
Company Filing History:
2 out of 15,964 
1 out of 1 Years Active: 2015-2017
Title: Innovations of William Michael Pennington
Introduction
William Michael Pennington is an accomplished inventor based in Cherry Hill, NJ (US). He has made significant contributions to the field of biochemistry, particularly in the development of analogs of ShK toxin. His work focuses on the selective inhibition of Kv1.3 potassium channels, which has important implications for treating various diseases and disorders.
Latest Patents
William Michael Pennington holds 2 patents. His latest patents include "Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels" and "Analogs of ShK toxin and methods for using such ShK analogs." These patents describe ShK analogs that consist of ShK toxin attached to a chemical entity with an anionic charge. The ShK analogs can be administered to both human and non-human animal subjects to inhibit potassium channels or treat diseases. The chemical entity may be selected to provide selective inhibition of specific potassium channels, such as Kv1.3 channels over Kv1.1 channels. Additionally, some embodiments include a fluorophore, allowing for the use of fluorophore-tagged ShK analogs in flow cytometry.
Career Highlights
Throughout his career, Pennington has worked with notable organizations, including the University of California and Bachem Americas, Inc. His research has contributed to advancements in the understanding of potassium channels and their role in various biological processes.
Collaborations
Some of his notable coworkers include K George Chandy and Christine Beeton. Their collaborative efforts have furthered research in the field of biochemistry and the development of therapeutic applications.
Conclusion
William Michael Pennington's innovative work in the field of biochemistry, particularly with ShK toxin analogs, showcases his dedication to advancing medical science. His contributions have the potential to lead to significant breakthroughs in the treatment of diseases related to potassium channel dysfunction.